World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
47
Citations
7087
World Ranking
6509
National Ranking
47

Abraham Fisher publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Abraham Fisher sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 163 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Abraham Fisher D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Abraham Fisher sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 47 D-Index — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Abraham Fisher is affiliated with the Israel Institute for Biological Research in Israel. Their research contributions span several interconnected fields with a primary focus on the biochemical and molecular biology aspects of neurological conditions.

Their scientific publications cover key areas within biochemistry, genetics, and molecular biology, alongside medicine. The three main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these fields, Fisher has explored subfields that further specify the nature of scientific inquiry, including:

  • Molecular Biology
  • Pharmacology
  • Cellular and Molecular Neuroscience

The scientific topics addressed in their work reflect a focus on neurodegenerative disease mechanisms and receptor function, such as:

  • Cholinesterase and Neurodegenerative Diseases
  • Nicotinic Acetylcholine Receptors Study
  • Phosphodiesterase function and regulation
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research

Fisher has coauthored research with several notable collaborators. Frequent coauthors include:

  • Ezio Giacobini
  • A. Claudio Cuello
  • Allan I. Levey

Fisher's publications appear in specialized venues relevant to neurology and brain research, including:

  • Brain
  • Handbook of clinical neurology

Among recent academic outputs, two papers stand out:

  • Reimagining cholinergic therapy for Alzheimer's disease (2022, Brain)
  • CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment (2025, Handbook of clinical neurology)

Their ongoing work evidently centers around cholinergic mechanisms in neurodegenerative diseases, with a specific emphasis on Alzheimer's disease therapies and receptor-targeted pharmacology.

Best Publications

  • M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice

    Antonella Caccamo;Salvatore Oddo;Lauren M. Billings;Kim N. Green

  • Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.

    A Fisher;C R Mantione;D J Abraham;I Hanin

  • Activation of m1 Muscarinic Acetylcholine Receptor Regulates τ Phosphorylation in Transfected PC12 Cells

    Einat Sadot;David Gurwitz;Jacob Barg;Leah Behar

  • AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.

    Thomas J. Walsh;Hugh A. Tilson;Diane L. DeHaven;Richard B. Mailman

  • M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

    Abraham Fisher;Zipora Pittel;Rachel Haring;Nira Bar-Ner

  • Cholinergic Treatments with Emphasis on M1 Muscarinic Agonists as Potential Disease-Modifying Agents for Alzheimer's Disease

    Abraham Fisher

  • Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease.

    Abraham Fisher

  • Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats.

    Charles R. Mantione;Michael J. Zigmond;Abraham Fisher;Israel Hanin

  • Mitogen-Activated Protein Kinase-Dependent and Protein Kinase C-Dependent Pathways Link the m1 Muscarinic Receptor to β-Amyloid Precursor Protein Secretion

    Rachel Haring;Abraham Fisher;Daniele Marciano;Zipora Pittel

  • Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

    David Gurwitz;Rachel Haring;Eliahu Heldman;Claire M. Fraser

  • Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.

    Abraham Fisher

  • Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?

    N. Bons;F. Rieger;D. Prudhomme;A. Fisher

  • Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.

    Unknown

  • Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline

    Rodrigo Medeiros;Masashi Kitazawa;Antonella Caccamo;David Baglietto-Vargas

  • Use of muscarinic agonists in the treatment of Sjögren's syndrome.

    Robert I. Fox;Yrjö Konttinen;Abraham Fisher

  • Selective cholinergic neurotoxin: AF64A's effects in rat striatum.

    K. Sandberg;I. Hanin;A. Fisher;J.T. Coyle

  • The AF64a-treated mouse: possible model for central cholinergic hypofunction.

    Unknown

  • Choline analogs as potential tools in developing selective animal models of central cholinergic hypofunction.

    Unknown

  • Progress In Alzheimer's And Parkinson's Diseases

    Abraham Fisher;Israel Hanin;充男 吉田;Makhon le-mehkar biyologi be-Yisraʾel

  • AF64A: An Active Site Directed Irreversible Inhibitor of Choline Acetyltransferase

    K. Sandberg;R. L. Schnaar;M. McKinney;I. Hanin

  • (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

    A Fisher;R Brandeis;I Karton;Z Pittel

  • Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B

    R. Brandeis;S. Dachir;M. Sapir;A. Levy

  • (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.

    A. Fisher;R. Brandeis;Z. Pittel;I. Karton

  • M1 Agonists for the Treatment of Alzheimer's Disease.

    A. Fisher;E. Heldman;D. Gurwitz;R. Haring

Frequent Co-Authors

David Gurwitz
David Gurwitz Tel Aviv University
Frank M. LaFerla
Frank M. LaFerla University of California, Irvine
Zvi Vogel
Zvi Vogel Weizmann Institute of Science
Eric Halgren
Eric Halgren University of California, San Diego
Daniel M. Michaelson
Daniel M. Michaelson Tel Aviv University
Frédéric Checler
Frédéric Checler Grenoble Alpes University
Adriaan A. Lammertsma
Adriaan A. Lammertsma VU University Medical Center
Ronit Pinkas-Kramarski
Ronit Pinkas-Kramarski Tel Aviv University
Joseph O'Neill
Joseph O'Neill University of California, Los Angeles
Antonella Caccamo
Antonella Caccamo University of Messina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open doors to a variety of interconnected fields that offer rewarding career opportunities and flexible online study options. Many students interested in brain science also consider programs in counseling, therapy, and psychology due to substantial overlap in curriculum and professional applications.

Several accredited online programs make it easier and more affordable than ever to advance your education. If you're looking for budget-friendly options, you might want to explore the cheapest cacrep-accredited programs online, as well as the cheapest master's in counseling online. Both can be excellent choices for those interested in supporting individuals or groups with neurological and psychological needs.

If your passion lies in helping families or couples, you may consider one of the online mft programs (Marriage and Family Therapy), which integrate aspects of neuroscience into their therapeutic approaches. Likewise, students aiming for a broader skill set in mental health and brain sciences can research masters programs in psychology for flexible learning and diverse career pathways. Many of these programs offer part-time and fully online formats to fit your schedule and goals.

Best Scientists Citing Abraham Fisher

Trending Scientists

Recently Published Articles